Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ana Bertha Rivera‑Ramírez"'
Autor:
Marco Antonio Leyva-Vázquez, Jorge Organista-Nava, Yazmín Gómez-Gómez, Ana Bertha Rivera-Ramírez, Mónica Virginia Saavedra-Herrera, Berenice Illades-Aguiar
Publikováno v:
Oncology Letters
Dihydrofolate reductase (DHFR) has an important function in DNA synthesis and is a target of methotrexate, which is a crucial treatment option for acute lymphoblastic leukemia (ALL). However, the number of studies conducted to date on DHFR expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::412ab90fcfbe8f85c4cba0cc4deeeeb7
http://europepmc.org/articles/PMC5950508
http://europepmc.org/articles/PMC5950508
Autor:
Yazmín Gómez-Gómez, Jorge Organista-Nava, Marco Antonio Leyva-Vázquez, Berenice Illades-Aguiar, Mónica Virginia Saavedra-Herrera, Marco Antonio Jiménez-López, Fernando Villanueva-Flores, Ana Bertha Rivera-Ramírez, José Silvestre Estrada-Brito
Publikováno v:
Archives of medical research. 50(4)
Background Polymorphisms in folate-related genes are closely related to the development of cancer. The 5,10-MTHFR 677C>T and RFC1 80G>A polymorphisms are associated with an increased risk of susceptibility to pediatric ALL. Objective The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96f217d3128a3a6ac9c9f423cee91565
https://pubmed.ncbi.nlm.nih.gov/31499477
https://pubmed.ncbi.nlm.nih.gov/31499477
Autor:
Víctor Hugo Garzón-Barrientos, Jorge Organista-Nava, Marco Antonio Leyva-Vázquez, Yazmín Gómez-Gómez, Ana Bertha Rivera‑Ramírez, Mónica Virginia Saavedra-Herrera, Luz del Carmen Alarcón-Romero, Berenice Illades-Aguiar
Publikováno v:
Oncology Reports
MicroRNAs (miRNAs) play an essential role in the development and progression of acute leukemia (AL). miR-24 promotes the survival of hematopoietic cells. However, little is known concerning the function of miR-24 in human AL. The aim of the present s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::434c5a3140c3c526e02ee37ce640c3ac
http://europepmc.org/articles/PMC4358084
http://europepmc.org/articles/PMC4358084
Autor:
Yazmín Gómez-Gómez, Berenice Illades-Aguiar, Jorge Organista-Nava, Ana Bertha Rivera-Ramírez, Luz del Carmen Alarcón-Romero, Mónica Virginia Saavedra-Herrera, Marco Antonio Terán-Porcayo, Marco Antonio Leyva-Vázquez
Publikováno v:
Experimental and Therapeutic Medicine. 3:665-672
Dihydrofolate reductase (DHFR) is the major target of methotrexate, a key component in childhood acute lymphoblastic leukemia (ALL) treatment. Polymorphisms in the gene coding for DHFR have been associated with adverse event treatment. This study eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4a8aaa27511850af34ff776f677b961
https://doi.org/10.3892/etm.2012.447
https://doi.org/10.3892/etm.2012.447
Autor:
Ricardo Aguilar-Guadarrama, Daniel Montante-Montes, Milena Saqui-Salces, Javier Camacho, María Del Rosario Solís-Pancoatl, Luz María Hinojosa, Elisabeth Hernández-Gallegos, Braulio Martínez-Benítez, Luis A. Pardo, Cindy Sharon Ortiz, Ana Bertha Rivera‑Ramírez, Patricio Gariglio, Enrique García-Villa, Walter Stühmer, Armando Gamboa-Domínguez
Publikováno v:
Oncology Reports.
Human ether à-go-go 1 (Eag1) potassium channels are potential tumor markers and therapeutic targets for several types of malignancies, including cervical cancer. Estrogens and human papilloma virus oncogenes regulate Eag1 gene expression, suggesting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2311753b067d891dc4a5fe6a8bd082
https://doi.org/10.3892/or.2011.1441
https://doi.org/10.3892/or.2011.1441
Autor:
Ana Bertha Rivera-Ramírez, Jorge Organista-Nava, Berenice Illades-Aguiar, Yazmín Gómez-Gómez, Luz del Carmen Alarcón-Romero, Marco Antonio Leyva-Vázquez, Mónica Virginia Saavedra-Herrera, Marco Antonio Terán-Porcayo
Publikováno v:
Leukemia research. 34(6)
This study evaluated the association of −401C/T and +452C/T polymorphisms of γ-glutamyl hydrolase and the risk of relapse to acute lymphoblastic leukemia. Genotyping was performed in 70 children with acute lymphoblastic leukemia and 140 healthy ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04af81c4e90dddfd82fb80115b1cb0e3
https://pubmed.ncbi.nlm.nih.gov/20197200
https://pubmed.ncbi.nlm.nih.gov/20197200